NovoCure Ltd·4

Mar 6, 4:41 PM ET

Puri Michal Nath 4

4 · NovoCure Ltd · Filed Mar 6, 2025

Insider Transaction Report

Form 4
Period: 2025-03-04
Puri Michal Nath
Chief Human Resources Officer
Transactions
  • Award

    Ordinary Shares

    2025-03-04$18.19/sh+54,975$999,995163,681 total
  • Award

    Stock Options (Right to buy)

    2025-03-04$18.19/sh+81,499$1,482,46781,499 total
    Exercise: $18.19From: 2026-03-04Exp: 2035-03-03Ordinary Shares (81,499 underlying)
Footnotes (2)
  • [F1]Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
  • [F2]Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT